- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder Cancer, Muscle-invasive
Total 15351 results
-
Memorial Sloan Kettering Cancer CenterRockefeller University; Pin Down Bladder Cancer Research FoundationRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
PfizerActive, not recruitingNon-muscle Invasive Bladder CancerChina, United States, Spain, Belgium, Korea, Republic of, Australia, United Kingdom, Japan, France, Germany, Canada, Russian Federation, Poland, Italy
-
UNICANCERHoffmann-La RocheActive, not recruitingBladder CancerSpain, France, Belgium
-
University of Rome Tor VergataUniversity of BariCompleted
-
University of SydneyAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Cancer...Active, not recruitingBladder CancerAustralia, United Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenUniversity of AarhusRecruitingNon-Muscle Invasive Bladder CancerDenmark
-
Paolo PuppoCompletedNon Muscle Invasive Bladder CancerItaly
-
University Hospital Inselspital, BerneUniversity of Bern; Hospital Centre Biel/BienneRecruitingBladder Cancer | Non-muscle InvasiveSwitzerland
-
Mayo ClinicRecruitingNon-muscle Invasive Bladder Cancer | Stage 0a Bladder Cancer AJCC v8 | NMIBCUnited States
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Institut Paoli-CalmettesNot yet recruitingNon-muscle-invasive Bladder Cancer
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
BioCis Pharma LtdTurku University Hospital; FinnMedi Oy; Tampere University HospitalCompletedCis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder CancerFinland
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
Case Comprehensive Cancer CenterWithdrawnNon-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)United States
-
Istituto Oncologico Veneto IRCCSFidia Farmaceutici s.p.a.Not yet recruiting
-
Fudan UniversityNot yet recruitingNon-muscle Invasive Bladder Cancer | HER-2 Protein Overexpression
-
Janssen Research & Development, LLCRecruitingUrinary Bladder NeoplasmsUnited States, Belgium, Korea, Republic of, Germany, Italy, France, Spain, Canada, United Kingdom, Greece, Japan, Netherlands, Portugal, Australia, Russian Federation, Ukraine
-
National Cancer Institute (NCI)CompletedUrinary Bladder NeoplasmsUnited States
-
King's College LondonRecruitingSurgery | Patient Satisfaction | Patient Preference | Muscle Invasive Bladder Cancer | Sexual WellbeingUnited Kingdom
-
Dokuz Eylul UniversityNot yet recruitingBladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical InstillationTurkey
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.RecruitingUrinary Bladder Cancer, Muscle-invasiveUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Mexico, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Thailand, T... and more
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Aarhus University HospitalActive, not recruitingNon-muscle Invasive Bladder CancerDenmark
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
CG Oncology, Inc.WithdrawnBladder Cancer | High Grade | Non Muscle InvasiveUnited States
-
National and Kapodistrian University of AthensCompleted
-
Genomic Health®, Inc.CompletedNon-muscle Invasive Bladder CancerUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
Early is Good Inc.RecruitingBladder CancerUnited States
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsKorea, Republic of, United States, United Kingdom
-
Theralase Inc.University Health Network, Toronto; WCCT Global; Medelis Inc.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCGCanada
-
UroGen Pharma Ltd.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma
-
University of MiamiTerminatedBladder Cancer | Bladder Carcinoma | Muscle Invasive Bladder Carcinoma | Transition Cell CancerUnited States
-
Bristol-Myers SquibbTerminatedUrinary Bladder NeoplasmsUnited States, Netherlands, Italy, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Greece, Israel, Japan, Russian Federation, Spain, Sweden
-
Janssen Research & Development, LLCActive, not recruitingUrinary Bladder NeoplasmsUnited States, Japan, China, Korea, Republic of, France, Belgium, Czechia, Taiwan, Italy, Poland, United Kingdom, Spain, Germany, Australia, Brazil, Argentina, India
-
Mansoura UniversityUnknownNon-Muscle-invasive Bladder Cancer (NMIBC) | Bacillus Calmette-Guerin (BCG) Cystitis | Intra-vesical InstillationEgypt
-
University of California, IrvineNot yet recruitingMuscle-Invasive Bladder Cancer | Urothelial Bladder CancerUnited States
-
Wroclaw Medical UniversityCompletedRecurrence | Progression | Biomarkers | Bladder Cancer | Non-muscle Invasive Bladder Cancer | CystoscopyPoland
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom